Antiepileptic Drug — Competitive Intelligence Brief

Antiepileptic Drug (Antiepileptic Drug) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiepileptic. Area: Neurology.

phase 2 Antiepileptic Voltage-gated sodium channels Neurology Small molecule

Target snapshot

Antiepileptic Drug (Antiepileptic Drug) — Istituti Clinici Scientifici Maugeri SpA. Blocks voltage-gated sodium channels

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Antiepileptic Drug TARGET	Antiepileptic Drug	Istituti Clinici Scientifici Maugeri SpA	phase 2	Antiepileptic	Voltage-gated sodium channels
Lidocaine (drug)	Lidocaine (drug)	Daniel A Tonetti, MD	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine solution ("A")	Lidocaine solution ("A")	Hospital Universitari de Bellvitge	marketed	Local anesthetic	Voltage-gated sodium channels
ESL	ESL	Bial - Portela C S.A.	marketed	Voltage-gated sodium channel blocker; anticonvulsant	Voltage-gated sodium channels (Nav)
lamotrigine (generic Teva)	lamotrigine (generic Teva)	University of Maryland, Baltimore	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
Control (bupivacaine)	Control (bupivacaine)	Kasr El Aini Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Lidocaine gel 2%	Lidocaine gel 2%	Atlantic Health System	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiepileptic class)

1. Istituti Clinici Scientifici Maugeri SpA · 1 drug in this class